Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety

Author： Reffelmann Thorsten Kloner Robert A

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 531-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for erectile dysfunction

By Bivalacqua T.J. Champion H.C. Hellstrom W.J.G. Kadowitz P.J.

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 484-489

Elsevier

Access to resources Recommend Favorite

The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease

Current Pharmaceutical Design, Vol. 14, Iss. 35, 2008-12 ,pp. : 3700-3714

Bentham Science Publishers

Access to resources Recommend Favorite

The future of the oral pharmacotherapy of male erectile dysfunction: things to come

By Ückert Stefan Mayer Margit E Stief Christian G Jonas Udo

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 219-228

Informa Healthcare

Access to resources Recommend Favorite

Current and future trends in the oral pharmacotherapy of male erectile dysfunction

By Ückert Stefan Stief Christian G Jonas Udo

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1521-1533

Informa Healthcare

Access to resources Recommend Favorite

Safety and Tolerability of Oral Erectile Dysfunction Treatments in the Elderly

By Salonia Andrea

Drugs & Aging, Vol. 22, Iss. 4, 2005-01 ,pp. : 323-338

Adis International

Access to resources Recommend Favorite